# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001485003-24-000015
Filing Date
2024-08-08
Accepted
2024-08-08 07:42:04
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | carm-20240630.htm iXBRL | 10-Q | 1366778
2 | EX-31.1 | carm-20240630xexx311.htm | EX-31.1 | 10677
3 | EX-31.2 | carm-20240630xexx312.htm | EX-31.2 | 10674
4 | EX-32.1 | carm-20240630xexx321.htm | EX-32.1 | 4987
5 | EX-32.2 | carm-20240630xexx322.htm | EX-32.2 | 4982
| Complete submission text file | 0001485003-24-000015.txt |  | 5508062

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | carm-20240630.xsd | EX-101.SCH | 43282
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | carm-20240630_cal.xml | EX-101.CAL | 54116
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | carm-20240630_def.xml | EX-101.DEF | 115817
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | carm-20240630_lab.xml | EX-101.LAB | 570127
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | carm-20240630_pre.xml | EX-101.PRE | 352585
67 | EXTRACTED XBRL INSTANCE DOCUMENT | carm-20240630_htm.xml | XML | 478298

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36296 | Film No.: 241186092
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)